Elyse A. Olesinski

Patterns of substrate affinity, competition and degradation kinetics underlie biological activity of thalidomide analogs.

S. Carr, A. Letai, B. Ebert, 2019, Blood.

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia.

Annette S. Kim, A. Letai, C. Paweletz, 2020, Cancer cell.

Formative evaluation prior to implementation of a brief treatment for posttraumatic stress disorder in primary care

S. Valentine, A. Elwy, N. Sarkisova, 2021, Implementation Science Communications.

BH3 Profiling Identifies Selective BCL-2 Dependence of Adult Early T-cell Progenitor (ETP) Subtype of Acute Lymphoblastic Leukemia (ALL) Patients

A. Letai, M. Konopleva, Jacqueline S. Garcia, 2021, bioRxiv.

Dynamic BH3 profiling method for rapid identification of active therapy in BH3 mimetics resistant xenograft mouse models

S. Bhatt, Elyse A. Olesinski, Shruti Bhatt, 2021, STAR protocols.